🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase 1-2 trial studies the side effects and how well tipifarnib works...
Status
Completed
Location
Stanford Cancer Institute
Start Date
2000-05
Trial ID
NCT02210858
Treatments Being Tested
The purpose of this study is to evaluate the objective response rate when Z...
Status
Terminated
Location
Institut Bergonie
Start Date
2003-08
Trial ID
NCT00210028
A Phase I, open-label clinical pharmacology study designed to evaluate the ...
Status
Terminated
Location
Gabrail Cancer Center Research
Start Date
2021-05-06
Trial ID
NCT04865159
Treatments Being Tested
Phase II study designed to investigate antitumor activity in terms of objec...
Status
Completed
Location
Stanford University Medical Center
Start Date
2016-02-25
Trial ID
NCT02464228
Treatments Being Tested
The goal of this clinical research study is to find the highest safe dose o...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2002-12
Trial ID
NCT00050986
Treatments Being Tested
A Phase 2 study to investigate the antitumor activity in terms of overall r...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-01-10
Trial ID
NCT02807272
Treatments Being Tested
To determine the EFFICACY and the SAFETY PROFILE and TOXICITY of Zarnestra®...
Status
Terminated
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00847223
Treatments Being Tested
The purpose of this study is to determine if the addition of tipifarnib to ...
Status
Completed
Location
Multiple Locations
Start Date
2002-09
Trial ID
NCT00050141
Treatments Being Tested
This randomized phase II trial is studying how well giving sorafenib togeth...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2007-08
Trial ID
NCT00281957
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2000-06
Trial ID
NCT00005833
Treatments Being Tested